Monday, September 21, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Compoundingbpc-157gray markettb-500direct-to-consumer

Women's Health documents DIY market for BPC-157 among women

Users interviewed describe self-reconstituting vials and building injection protocols after what they call failures of conventional care.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 21 06:00 ETSource: Women's Health

The wire

  1. 01The magazine reports peptide content has topped 130,000 Instagram posts and 230 million TikTok views as of May 2026, with women sourcing BPC-157 and others for injury and hormonal complaints.
  2. 02Clinicians and pharmacists are increasingly seeing patients already on self-directed gray-market protocols sourced outside any prescriber relationship.
  3. 03The piece notes BPC-157 lacks the clinical trial record behind approved peptide drugs, and its accounts are self-reported user experiences, not outcome data.

From the source

Inside the Underground World of DIY Peptides

Gina, a Californian in her 40s, was a true early adopter. She first heard about peptides eight or nine years ago, and as a very active woman with a few sports injuries, she was drawn to compounds like Body Protection Compound 157 (BPC-157) for their supposed healing properties. She initially opted for pills rather than injections: “At the time, I chickened out and bought the oral pills, even thoug

Read at womenshealthmag.com